Pellet Therapy: The Revolutionary Way to Balance Your Hormones
Hormone pellet therapy may feel like the latest development in personalized medicine, but its roots stretch back nearly a century. What has evolved is our understanding of why it works so well, our ability to precisely dose individual patients, and the quality of evidence supporting its use. Today, pellet therapy represents one of the most physiologically sound methods of hormone delivery available — and for many patients, it marks a turning point after years of incomplete symptom relief from other approaches.
A Brief History of Pellet Therapy
The use of subcutaneous hormone implants dates to the late 1930s, when researchers in Europe first demonstrated that compressed hormone pellets placed under the skin could deliver estrogen continuously over weeks and months. By the 1940s, physicians in both Europe and the United States were using estrogen and testosterone pellets for menopausal management. The treatment fell out of widespread use in the United States during the era of pharmaceutical HRT dominance in the latter half of the 20th century, but it never disappeared entirely — particularly in Australia, where pellet therapy remained in routine clinical use and accumulated an extensive long-term outcomes record.
The resurgence of pellet therapy in the United States over the past two decades has been driven by growing demand for bioidentical hormones, increasing patient awareness of the limitations of synthetic HRT, and a growing body of clinical research documenting pellets' advantages in hormone level stability and patient satisfaction.
How Subcutaneous Implants Work
Hormone pellets are small, cylindrical implants — roughly 3 mm in diameter and 9 mm in length — made from pure, compounded bioidentical hormones compressed under high pressure. Most commonly, they contain testosterone, estradiol, or both, formulated by a licensed compounding pharmacy to the specific dose prescribed by the treating physician.
The pellet is inserted into the subcutaneous fat of the upper outer buttock through a small incision using a sterile trocar. Once in place, it begins to dissolve slowly as the surrounding tissue breaks down the compressed hormone matrix. The rate of dissolution — and therefore hormone release — is influenced primarily by blood flow, which naturally increases with physical activity. This creates an adaptive delivery mechanism: during exercise, when the body's demand for hormones is higher, release rate increases modestly. At rest, it slows. This dynamic is unique to pellet delivery and cannot be replicated by any fixed-dose external system.
Physiologic Delivery Advantages
The advantages of subcutaneous delivery over oral or topical routes are rooted in physiology. Oral hormones undergo first-pass metabolism in the liver before entering systemic circulation, which increases the production of clotting factors and sex hormone-binding globulin (SHBG). Elevated SHBG reduces the amount of free — and therefore biologically active — hormone available to tissues. Subcutaneous delivery bypasses the liver entirely, entering the bloodstream directly in a form that closely mirrors how the body's own glands release hormones.
Topical creams and gels bypass first-pass hepatic metabolism as well, but they introduce absorption variability that pellets do not have. Skin thickness, temperature, moisture, and application technique all affect how much of a cream dose actually reaches the bloodstream. The subcutaneous implant removes these variables and provides a consistent, predictable hormone source for the entire duration of the pellet's life.
The result is hormone levels that are stable, physiologic, and maintained continuously — not just in the hours immediately after an application or injection. For patients who have experienced the mood swings, energy drops, and symptom variability associated with other delivery methods, this stability is often described as transformative.
Dr. Bruice's Approach to Pellet Therapy
Dr. Kenton Bruice MD approaches pellet therapy as a precise, individualized medical intervention — not a standardized procedure. Every patient begins with a comprehensive laboratory evaluation and symptom assessment. Pellet doses are calculated based on hormone levels, body weight, activity level, and symptom profile. Follow-up labs are obtained 4–6 weeks after each insertion to confirm that target levels have been achieved and to guide dose refinement.
Over time, the protocol is progressively refined based on each patient's response, producing increasingly consistent results with each treatment cycle. Dr. Bruice's patients in Denver, Aspen, and St. Louis benefit from both the precision of individualized dosing and the convenience and physiologic advantages that only pellet therapy can provide.
If you are ready to experience what balanced, stable hormones can do for your energy, mood, body composition, and quality of life, contact Dr. Kenton Bruice MD to schedule your initial consultation.